Quantitative Imaging: A Revolution in Evolution

| | Health Imaging | Artificial Intelligence

Thursday, Nov. 29, 8:30-10:00 a.m.| N229

This session explores quantitative imaging and how it might revolutionize the practice of radiology. Speakers review research advances and current clinical applications and discuss challenges of quantitative imaging.

Speaker Information:

  • Luciano Monte Serrat Prevedello, MD, Brigham and Women’s Hospital, Boston  
  • Adam E. Flanders, MD, Thomas Jefferson University Hospital, Philadelphia
  • Katherine P. Andriole, PhD, Brigham and Women’s Hospital, Boston
  • Daniel L. Rubin, MD, Stanford University Medical Center, Stanford, Calif.
  • Eliot L. Siegel, MD, University of Maryland Medical Center, Baltimore

Related Content

Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
Can large language models break language barriers in radiology reports?

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.